2-(tert-Butyldimethylsilyl)-N,N-dimethyl-1H-imidazole-1-sulfonamide, 97.0%, 1g

3-n-Butylthiobenzyl alcohol, 97.0%, 1g

Ethyl 2-amino-4-(trifluoromethyl)-5-thiazole-carboxylate, 97.0%, 1g

DIETHYL PHOSPHORAMIDATE, 95%, 25g

GAMBOGIC ACID, 98%, 5mg

Methyl 3-amino-4-fluorobenzoate, 95.0%, 25g

2,6-Dihydroxyquinoline, 95.0%, 25g

2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)isothiazolidine 1,1-dioxide, 98%, 1g

Filtration unit Stericup® with Durapore® (PVDF) membrane Pore size 0.45 μm, 150 ml, 150 ml, 12 Piece(s)

1-(4-Ethoxyphenyl)-2-thiourea, 98.0%, 10g

1-Cinnamoylpiperazine, 96.0%, 2g

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-cyclohexylglycine>98.0%(HPLC)(T)1g

rel-((1R,5S)-3-Azabicyclo[3.1.0]hexan-6-yl)methanol, 95+%, 100mg